Health Care Quality and Patient Safety
ODPHP is committed to achieving high-quality health care for all Americans. Our initiatives aim to increase patient safety through prevention strategies focused on adverse drug events, health care-associated infections, and other aspects of patient care.
News & Announcements
Read this post
September 12, 2017 | 9:00 a.m. – 4:00 p.m. ET | Register
The Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research, Professional Affairs and Stakeholder Engagement Staff, is hosting a one day public workshop entitled “Reducing the Risk of Preventable Adverse Drug Events Associated with Hypoglycemia in the Older Population.” During the workshop, public and federal partners will discuss:
The importance of individualizing glycemic control targets for older patients with diabetes
Risk reduction for serious hypoglycemia
Medication safety efforts, both those that are a part of FDA’s Safe Use Initiative and those external to the FDA, that are relevant and important to older adults living with diabetes
Future areas of research
The National Action Plan for Adverse Drug Event Prevention identifies hypoglycemia as a common, clinically significant, and preventable adverse effect from diabetes agents that can cause serious harm to patients.…
Many ADEs (injuries that result from medical intervention related to a drug) are preventable. Our national action plan to prevent ADEs seeks to engage leaders at all levels to use evidence-based guidelines and strategies to help prevent ADEs.
HAIs (infections people get while they are receiving health care) are a significant cause of illness and death. Our national action plan to reduce HAIs provides a road map for preventing HAIs in health care facilities.
This interactive training for health professionals promotes the appropriate, safe, and effective use of opioids to manage chronic pain.
This online video-simulation training program focuses on HAI prevention for clinicians, health professional students, and patient advocates.